Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
TQB3303
/
Sino Biopharm, Shouyao Holdings
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
||
||||||||
TQB3303
/
Sino Biopharm
New P1 trial:
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3303 Tablets
(clinicaltrials.gov) - Feb 19, 2020
P1
, N=40, Not yet recruiting,
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.